Skip to main content
Log in

In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

PSK, a protein-bound polysaccharide, has been widely used for cancer immunotherapy in Japan. However, the mechanism of its immunomodulatory effect has not been fully clarified. In the present study the in vitro effect of PSK on the lymphocytes of patients with gastric cancer was studied. Culturing lymphocytes with PSK at 5–100 µg/ml increased the level of DNA synthesis, and augmented the cytotoxicities against K562 and KATO-3. Flow-cytometric analysis also showed an increase in the proportion of interleukin-2 (IL-2)-receptor-positive cells after the lymphocytes were cultured with PSK. However the cytotoxicity of cells cultured with PSK was not augmented by the addition of recombinant interferon γ (rIFNγ) and rIL-2. Further experiments using fractionated PSK showed that its biological action is present mainly in fractions having molecular masses >105Da. However, these immunomodulations were not seen in all patients. These results suggest that the susceptibility of lymphocytes to PSK may be different in each patients, and that the immunomodulation by PSK may be mediated by mechanisms independent of IFN and IL-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Akiyama J, Kawamura T, Gotohda E, Yamada Y, Hosokawa M, Kodama T, Kobayashi H (1077) Immunochemotherapy of transplanted KMT-17 tumor WKA rated by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Cancer Res 37: 3042–3045

    Google Scholar 

  2. Ebihara K, Minamishima Y (1984) Protective effect of biological response modifiers on murine cytomegalovirus infection. J Virol 51: 117–122

    Google Scholar 

  3. Ebina T, Kohya H (1988) Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation. Jpn J Cancer Res (Gann) 79: 957–964

    Google Scholar 

  4. Ebina T, Kohya H, Yamaguchi T, Ishida N (1986) Antimetastatic effect of biological response modifiers in the “double grafted tumor system”. Jpn J Cancer Res (Gann) 77: 1034–1042

    Google Scholar 

  5. Ehrke MJ, Reino JM, Eppolito C, Mihich E (1983) The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens. Int J Immunopharmacol 5: 35–42

    Google Scholar 

  6. Hosokawa M, Mizukoshi T, Morikawa K, Xu Z, Kobayashi H (1986) The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites. Cancer Immunol Immunother 22: 181–185

    Google Scholar 

  7. Kano T, Kumashiro R, Tamada R, Kodama Y, Inokuchi K (1981) Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach. Jpn J Surg 11: 291–296

    Google Scholar 

  8. Kato H, Kin R, Yamamura Y, Tanigawa M, Sano H, Sugino S, Kondo M (1987) Tumor inhibitory effect of polymorphonuclear leukocytes (PMN) induced by PSK in the peritoneal cavity of tumorbearing mice. J Kyoto Prefect Univ Med 96: 927–938

    Google Scholar 

  9. Kikuchi Y, Kizawa I, Oomori K, Iwano I, Kita T, Kato K (1988) Effects of PSK on interleukin-2 production by peritoneal lymphocytes of patients with advanced ovarian carcinoma during chemotherapy. Jpn J Cancer Res (Gann) 79: 125–130

    Google Scholar 

  10. Kitani H, Tsuru S, Oguchi M, Watanabe M, Zinnaka Y (1984) Effect of PSK in interferon production in tumor-bearing mice. J Clin Lab Immunol 15: 211–214

    Google Scholar 

  11. Kondo T, Sakamoto J, Ichihashi H, Kamei H (1981) Effect of alternating administration of PS-K and carbazilquinone in tumor-bearing mice. Jpn J Cancer Res (Gann) 72: 293–299

    Google Scholar 

  12. Mickey DD (1985) Combined therapeutic effects on an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma. Cancer Chemother Pharmacol 15: 54–58

    Google Scholar 

  13. Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, Amano T, Takahashi T, Murayama N, Oka H, Ooya K, Noto T, Ogawa N (1989) Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Jpn J Cancer Chemother 16: 2241–2249

    Google Scholar 

  14. Mizushima Y, Yuhki N, Hosokawa M, Kobayashi H (1982) Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats. Cancer Res 42: 5176–5180

    Google Scholar 

  15. Nakazato H, Koike A, Ichihara H, Saji S, Danno M, Ogawa N (1989) An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report) — a randomized controlled trial by the cooperative study group. Jpn J Cancer Chemother 16: 2563–2576

    Google Scholar 

  16. Nio Y, Tsuchitani T, Imai S, Shiraishi T, Kan N, Ohgaki K, Tobe T (1988) Immunomodulating effects of oral administration of PSK: II. Its effects on mice with cecal tumors. J Jpn Soc Cancer Ther 23: 1068–1076

    Google Scholar 

  17. Ogoshi K, Mitomi T (1989) Clinical effects of PSK on esophageal and gastric cancer patients and usefulness of serum level of glycoproteins and HLA antigens as prognostic indicators. J Jpn Surg Soc 90: 1443–1446

    Google Scholar 

  18. Ohno R, Yamada K, Masaoka T, Ohshima T, Amaki I, Hirota Y, Horikoshi N, Horiuchi A, Imai K, Kimura I, Kitajima K, Nakamura H, Nakamura T, Ohta Y, Sakai Y, Tanaka M, Tsubaki K, Uchino H, Ogawa N, Kimura K (1984) A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation. Cancer Immunol Immunother 18: 149–154

    Google Scholar 

  19. Toge T, Yamaguchi Y, Kegoya Y, Baba N, Yanagawa E, Hattori T (1989) Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK. Int J Immunopharmacol 11: 9–12

    Google Scholar 

  20. The General Rule for Gastric Cancer Study (1985) 11th edn, Japanese research Society, Kanehara Syuppan

  21. Tsuchiotani T, Nio Y, Imai S, Shiraishi T, Kan N, Ohgaki K, Tobe T (1987) Effects of oral administration of PSK on immune responses. I. Correlation ofin vivo effects within vitro biological activity. J Jpn Soc Cancer Ther 22: 1195–1202

    Google Scholar 

  22. Tsukagoshi S (1975) Fundamental approaches to cancer immunotherapy using a protein-bound polysaccaride, PSK, with special reference to its clinical application. In: Host Defense against Cancer and its Potentiation, ed., D. Mizuno et al. Univ. of Tokyo Press, Tokyo/Univ. Park Press, Baltimore, pp 365–377

    Google Scholar 

  23. Tsuru S, Nomoto K (1983) Effects of PSK on specific tumor immunity to syngeneic tumor cells. J Clin Lab Immunol 14: 215–219

    Google Scholar 

  24. Usui S, Urano M, Koike S, Kobayashi Y (1976) Brief communication: Effect of PSK, a protein polysaccharide, on pulmonary metastases of a C3H mouse squamous cell carcinoma. J Natl Cancer Inst 56: 185–187

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nio, Y., Shiraishi, T., Tsubono, M. et al. In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood, regional nodes, and spleen lymphocytes in patients with gastric cancer. Cancer Immunol Immunother 32, 335–341 (1991). https://doi.org/10.1007/BF01741328

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741328

Key words

Navigation